Evidence map›Paper›PMID 20309009›Full record

ArticleImmunology and cell biology2010

Distinct roles of cytolytic effector molecules for antigen-restricted killing by CTL in vivo.

Edith M Janssen, Ed E Lemmens, Naina Gour, Rachel A Reboulet, Douglas R Green, Stephen P Schoenberger, Michael J Pinkoski

Open access · greenAbstract read
In one paragraph

Article in Immunology and cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Immunotherapy in Head and Neck Cancer.Cancer treatment and research · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Edith M JanssenDivision of Molecular Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Ed E Lemmens
Naina Gour
Rachel A Reboulet
Douglas R Green
Stephen P Schoenberger
Michael J Pinkoski
Cincinnati Children's Hospital Medical Center · USLa Jolla Institute for Immunology · USNIHR Leicester Biomedical Research Centre · GBSt. Jude Children's Research Hospital · US

Funding

Non-canonical functions of autophagy proteinsR01AI040646 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1997 to 2023
$8.6M
Survival Function of the Fadd-Caspase-8-Flip ComplexR01AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1999 to 2016
$6.3M
THE ANTI-APOPTOTIC ROLE OF HEATSHOCK PROTEIN 70 (HSP 70)R01AI047891 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2000 to 2014
$5.2M
Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT ExtensionR37AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2017 to 2026
$4.5M
Mechanisms of Stress Induced Apoptosis in T-CellsR37GM052735 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2002 to 2011
$4.1M
TRAIL-mediated regulation of T help for CTLR01CA081261 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2000 to 2009
$2.7M
Programming of CD8+ T Cell Tolerance by B Cell APCR01AI076972 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHOENBERGER, STEPHEN PHILIP · 2007 to 2011
$2.5M
T cell memory to cell-associated antigens by a new DC subsetR21AI079545 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI JANSSEN, EDITH M · 2008 to 2009
$413k
Medical Research CouncilNCI NIH HHS R01 CA081261NIAID NIH HHS R01 AI040646NIAID NIH HHS R01 AI044828NIAID NIH HHS R01 AI047891NIAID NIH HHS R01 AI076972NIAID NIH HHS R0 AI44828NIAID NIH HHS R21 AI079545NIGMS NIH HHS R37 GM052735
6 · The paper itself

Abstract

Cytotoxic T lymphocytes (CTLs) represent one of the front lines of defense for the immune system, killing virus-infected and tumor-transformed cells. CTL use at least two mechanisms to induce apoptosis in their targets, one mediated by perforin and granzymes, and the other triggered by the death ligand, CD95 ligand (CD95L). Here, we used an in vivo cytotoxicity assay to measure specific clearance of antigen-bearing target cells in mice that had previously been immunized with noninfectious cell-associated antigens. We found that perforin was dispensable for efficient clearance of antigen-bearing cells from immunized mice, but only if CD95/CD95L was functional; however, there was a delay in target cell clearance in the absence of perforin. In addition, we observed ∼35% target cell clearance in the absence of both perforin and CD95L, which was only slightly abrogated in the presence of a neutralizing anti-tumor necrosis factor (TNF) antibody. The presence of a dominant negative Fas-associated death domain (FADD) did not block target cell clearance and therefore cannot be attributed to known death receptors. Taken together, these data suggest that perforin- and CD95L-dependent killing are complementary at early time points, each can compensate for the absence of the other at later time points, and that there is an additional component of antigen-restricted CTL killing independent of perforin, CD95L, and TNFα.

Indexed as

Adoptive TransferAnimalsCytotoxicity, Immunologicfas ReceptorMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPerforinT-Lymphocytes, CytotoxicTumor Necrosis Factor-alphafas ReceptorPerforinTumor Necrosis Factor-alpha

Identifiers

PMID20309009
PMCPMC2939217
OpenAlexW1993610363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.